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Abstract
The nuclear lamina is a major obstacle encountered by herpesvirus nucleocapsids in their passage from the nucleus to the
cytoplasm (nuclear egress). We found that the human cytomegalovirus (HCMV)-encoded protein kinase UL97, which is
required for efficient nuclear egress, phosphorylates the nuclear lamina component lamin A/C in vitro on sites targeted by
Cdc2/cyclin-dependent kinase 1, the enzyme that is responsible for breaking down the nuclear lamina during mitosis.
Quantitative mass spectrometry analyses, comparing lamin A/C isolated from cells infected with viruses either expressing or
lacking UL97 activity, revealed UL97-dependent phosphorylation of lamin A/C on the serine at residue 22 (Ser
22). Transient
treatment of HCMV-infected cells with maribavir, an inhibitor of UL97 kinase activity, reduced lamin A/C phosphorylation by
approximately 50%, consistent with UL97 directly phosphorylating lamin A/C during HCMV replication. Phosphorylation of
lamin A/C during viral replication was accompanied by changes in the shape of the nucleus, as well as thinning,
invaginations, and discrete breaks in the nuclear lamina, all of which required UL97 activity. As Ser
22 is a phosphorylation
site of particularly strong relevance for lamin A/C disassembly, our data support a model wherein viral mimicry of a mitotic
host cell kinase activity promotes nuclear egress while accommodating viral arrest of the cell cycle.
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Introduction
Human cytomegalovirus (HCMV) is a pathogen that is
especially dangerous in immunocompromised individuals [1]. As
is true for all viruses, HCMV replication depends on the interplay
between viral and host cell functions. An important example of this
interplay is nuclear egress, a stage during which herpesviral DNA-
containing capsids (nucleocapsids) exit the nucleus [2]. An
important obstacle for the exiting nucleocapsids is a meshwork
underlying the inner nuclear membrane known as the nuclear
lamina, whose principal components are intermediate-filament
proteins known as lamins [3,4]. There are two major classes of
lamins in mammalian cells: A-type lamins, which comprise the
four lamins encoded by alternative splicing from the LMNA gene,
lamin A, AD10, C, and C2 (collectively lamin A/C), and B-type
lamins (lamin B), which are encoded by the LMNB1 and LMNB2
genes. A major function of lamins is to help maintain the structure
of the nuclear envelope. Accordingly, along with the nuclear
envelope, the nuclear lamina must be disassembled during mitosis
and then reassembled after mitosis. These dynamic processes are
regulated by phosphorylation of lamins. In particular, it is well
established that Cdc2/cyclin-dependent kinase (CDK) 1 disassem-
bles nuclear lamina by phosphorylation of specific sites on lamins
during mitosis [5,6,7]. CDK1 phosphorylation of lamin A/C at
Ser
22, and of lamin B at the equivalent position, have been shown
to be especially crucial for lamina disassembly [5,8]. It is thought
that phosphorylation at this site interferes with head-to-tail
interactions between lamins (reviewed in [3,4]). HCMV arrests
PLoS Pathogens | www.plospathogens.org 1 January 2009 | Volume 5 | Issue 1 | e1000275cells at the G1/S boundary during the cell cycle [9,10,11], and
therefore is unable to utilize this normal pathway for dissolution of
the nuclear lamina for nuclear egress. Interestingly, despite the
G1/S arrest, CDK1 and cyclin B are upregulated in HCMV-
infected cells [12,13,14]. However, these proteins do not appear to
accumulate in the nuclei of infected cells to the extent seen in
mitotic cells [14].
It has been proposed, initially from work on murine cytomega-
lovirus (MCMV), that a complex of two viral polypeptides (UL50 and
UL53 for HCMV) recruits calcium-dependent protein kinases C
(PKCs), to the nuclear envelope to phosphorylate lamins, disrupt the
nuclear lamina, and permit nuclear egress [15,16,17]. There is
evidence that PKC phosphorylation of lamins is important for
dissolution of nuclear lamina (e.g. [18]). However, it has not been
demonstrated that recruitment of PKC is sufficient or necessary to
cause lamin disruptions during HCMV infection or to permit nuclear
egress of HCMV. On the other hand, an unusual protein kinase,
UL97, which is encoded by HCMV, has been shown to be required
at the stage of nuclear egress for efficient replication of HCMV [19].
Some evidence for UL97 effects on nuclear lamina components has
been presented [20]. Interestingly, it has recently been shown that
UL97 has activities similar to those of CDKs (as hypothesized [21]),
but is not subject to cellular inhibitors of CDK function [22]. UL97 is
also a target for specific inhibition by a new antiviral drug, maribavir
[23], which is currently in phase III clinical trials.
In this study, using purified UL97, we show that UL97
phosphorylates lamin A in vitro on Ser
22, a site utilized by
CDK1 to mediate lamin disassembly. In HCMV-infected cells, we
detected UL97-dependent phosphorylation of lamin A/C at Ser
22,
and inhibition of phosphate incorporation into lamin A/C by
maribavir. Finally, morphological alterations in the host cell
nucleus and nuclear lamina during HCMV infection were
observed to depend on UL97. Taken together, our data argue
that UL97 directly phosphorylates lamin A/C during HCMV
replication to promote lamin disassembly during nuclear egress.
Results
Identification of lamin A/C as a candidate substrate of
UL97
To investigate the role(s) of UL97 during HCMV infection, we
searched for candidate substrates of UL97 by implementing a
proteomics strategy. Human foreskin fibroblast (HFF) cells
infected with wild-type (wt) HCMV strain AD169 (multiplicity of
infection (MOI)=1), with a UL97 deletion mutant (RCD97) [24],
or with wt virus under conditions where UL97 was pharmacolog-
ically inhibited using maribavir [23] were radiolabeled with
32P
orthophosphate, and the proteins were separated on 2-dimension-
al gels (Figure S1). Spots containing labeled phosphoproteins from
wt-infected cells that differed from those from the other conditions
were excised from the gels, digested with trypsin, and analyzed by
liquid chromatography-tandem mass spectrometry (LC-MS/MS).
A number of polypeptides were identified; these are tabulated in
Table S1. The protein for which the most peptides were identified
was lamin A/C, which is a major component of the nuclear
lamina [3,4]. Given that HCMV UL97 is important at the stage of
nuclear egress [19] and that the nuclear lamina forms a barrier to
nuclear egress, we hypothesized that UL97 phosphorylates lamin
A/C to mediate nuclear egress.
Purified UL97 phosphorylates lamin A in vitro on sites
phosphorylated by CDK1
A previous report [20] described the phosphorylation of lamins
in anti-FLAG immunoprecipitates from lysates of cells in which
FLAG-UL97 was expressed by transfection, but only when lamins
were simultaneously immunoprecipitated by anti-lamin antibod-
ies. No controls in which lamins were immunoprecipitated, but
UL97 was absent or inactive were shown. Thus, it was not
demonstrated that UL97 directly phosphorylates lamins. Addi-
tionally, sites of phosphorylation were not reported.
We wished to determine whether UL97 can directly phosphor-
ylate the largest of the A-type lamins, lamin A, in vitro. We
expressed lamin A fused to a histidine tag at its N-terminus, and
purified it from E. coli (Figure S2). When incubated with purified
enzymatically active UL97 fusion protein (GST-UL97) and c-
[
32P]-ATP, both GST-UL97 and lamin A became radiolabeled
(Figure 1A). However, labeling of lamin A was not observed in the
absence of added enzyme, and was almost completely abolished
when an equivalent quantity of a catalytically deficient mutant
form of GST-UL97 (K355Q) was used in place of wild-type GST-
UL97 (Figure 1A). Moreover, treatment with maribavir, a specific
inhibitor of UL97 activity, reduced phosphorylation of lamin A by
GST-UL97 with a dose-dependence very similar to its inhibition
of autophosphorylation of GST-UL97 (Figure 1B). Thus, UL97
phosphorylates lamin A in vitro.
To map the sites on lamin A that are phosphorylated by UL97
in vitro, proteins from kinase reactions, such as those conducted in
Figure 1A — except using unlabeled ATP — were digested with
trypsin. Phosphopeptides were enriched, and the peptides
analyzed by LC-MS/MS. Two major phosphorylated peptides
on lamin A were reproducibly detected following phosphorylation
by GST-UL97. One of these peptides (residues 12–25) was
unambiguously phosphorylated on Ser
22, a site whose phosphor-
ylation by CDK1 is crucial for lamin disassembly [5]. A
representative MS/MS spectrum showing Ser
22 phosphorylation
in tryptic peptides released from lamin A incubated with GST-
UL97 is presented in Figure 2A. A second major peptide including
Ser
390 and Ser
392 was clearly phosphorylated, but in the initial
analysis there was ambiguity as to which of these serines was
phosphorylated (see further analysis below). Three other phos-
phorylated peptides– one containing Ser
414, one Ser
628, and one
Ser
652 (Table 1) — were detected more than once, but less
frequently than the two major peptides. No phosphopeptides were
reproducibly detected in reactions using GST-UL97 K355Q or in
reactions containing GST-UL97 and 1 mM maribavir (data not
shown).
Author Summary
Human cytomegalovirus (HCMV) causes life-threatening
disease in transplant patients and people with AIDS, and is
also an important cause of birth defects. Like all viruses,
HCMV must have a way to leave the host cell, so that it can
infect new cells. Moreover, as a member of the herpesvirus
family, HCMV replicates its DNA in the nucleus, so it must
have mechanisms to ensure that its genetic material can
exit from the nucleus (nuclear egress). HCMV encodes a
protein kinase, UL97, which is required for efficient nuclear
egress. We found that UL97 aids nuclear egress by
mimicking a host cell enzyme that normally helps break
down a protein meshwork in the nucleus during cell
division. The enzyme activity of UL97 pokes holes in the
meshwork that allow nascent HCMV virions to gain access
to the nuclear membrane. UL97 is also an important target
for drugs for treating HCMV disease. This work not only
helps explain how these drugs act, but also highlights the
potential of targeting nuclear egress for the discovery of
new drugs.
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by GST-UL97 on the second major peptide, we used an
isotopically labeled synthetic peptide phosphorylated at Ser
392 to
identify fragment ions diagnostic for this phosphorylation site. As
an additional control, we also treated lamin A with a commercial
preparation of CDK1/cyclin B1 complex. For both GST-UL97
and CDK1/cyclin B1 treated samples of recombinant lamin A, no
phosphopeptides matching the fragmentation pattern for phos-
phorylation at Ser
392 were detected. Instead, a tryptic peptide
(387–397) with phosphorylation at Ser
390 was detected (Table 1,
Figure 2B and 2C). Evidently, phosphorylation at Ser
390 by UL97
or by CDK1 inhibited tryptic cleavage at Arg
388. Possible reasons
why we observed CDK1 phosphorylation on Ser
390 rather than
the more generally accepted site, Ser
392 [7] include folding of the
E. coli expressed lamin A altering the in vitro site specificity of
CDK1. Reexamination of the original study [7] suggests that the
data presented are consistent with a mixture of peptides; the
peptide reported, which is phosphorylated at Ser
392, and the
longer peptide that we detected, which is phosphorylated at Ser
390.
Interestingly, CDK1 mediated phosphorylation of murine A-type
lamins at Ser
390 in vitro has been previously suggested [25].
Regardless, UL97 phosphorylates lamin A in vitro on two sites,
Ser
22 and Ser
390, that are phosphorylated in vitro by CDK1
(Figure 2, data not shown, and [5,6,7]).
UL97-dependent phosphorylation of lamin A/C at Ser
22
during HCMV replication
To examine the role of UL97 in lamin A/C phosphorylation
during HCMV infection, we infected cells with wild type (wt)
HCMV strain AD169 at an MOI of 1, and at 72 hours post-
infection (p.i.) prepared cell lysates from which we immunopre-
cipitated lamin A/C. We then subjected the lamin A/C
immunoprecipitates to tryptic digestion and LC-MS/MS to
examine the pattern of phosphorylation (Table 1). Ser
22
phosphorylation was again detected (Figure 2D provides an
example from an iTRAQ labeling experiment — see below). A
phosphopeptide containing either Ser
390 or Ser
392 was also
detected, but in this case, with the aid of the isotopically labeled
synthetic peptide phosphorylated at Ser
392, the site of phosphor-
ylation was unambiguously identified as Ser
392 (Figure 2E). The
longer tryptic peptide containing Ser
390 that was observed
following in vitro phosphorylation was not detected in the lamin
A/C immunoprecipitates. Four other phosphorylation sites were
also detected (Ser
403, Ser
406/407, Ser
423, Thr
424), which are either
identical or in close proximity (Ser
404) to sites previously detected
in studies of phosphorylated proteins from human cells not
infected by HCMV [26,27,28,29].
As mutational analysis implicates Ser
22 and toalesserextentSer
392
in lamin A/C disassembly [5], we employed an iTRAQ
TM-based
quantitative MS approach [30] to evaluate whether levels of
phosphorylation on these Ser residues were influenced by UL97
during HCMV replication. Cells were infected at an MOI of 1 with
wt HCMV or a UL97 deletion mutant, D97 [31] or a virus in which
the deletion mutation was rescued [31] and lamin immunoprecip-
itates were prepared at 72 hours p.i. Following digestion with trypsin,
peptides from each sample were labeled with a sample-specific
iTRAQ reagent. Stable isotopes incorporated into these reagents
permit pooling of samples after labeling and subsequent relative
quantification of phosphopeptide abundances by LC-MS/MS. In
two separate experiments, while levels of Ser
392 phosphorylation did
not vary between lamin A/C isolated from wt-infected vs. D97-
infected cells, there were 2–3 fold higher levels of phosphorylation of
Ser
22 inlaminA/CfromwtHCMV-infectedcellscomparedtolamin
A/C from D97-infected cells (Table 2). Furthermore, lamin A/C
from cells infected with the virus in which the deletion was rescued
also showed approximately 2-fold higher levels of Ser
22 phosphor-
ylation compared to that from cells infected with D97 (Table 2).
Another pair of previously described mutant and rescuant viruses was
also compared, one encoding a catalytically-deficient form of UL97
(AD K355Q), and the other a rescuant of AD K355Q, in which
sequences encoding a wild-type UL97 were restored (AD Q355K)
[22]. In this experiment, lamin A/C from cells infected with the
rescuant (AD Q355K) had 4.1-fold higher levels of Ser
22 phosphor-
yation than that from AD K355Q-infected cells (Table2). From these
results,weconcludethatthereisUL97-dependentphosphorylationof
lamin A/C at Ser
22 during HCMV infection.
Transient inhibition of UL97 decreases lamin A/C
phosphorylation during viral replication
As a second approach to investigating the dependence of lamin
A/C phosphorylation on UL97, we performed radiolabeling
Figure 1. In vitro phosphorylation of lamin A by GST-UL97. (A)
Recombinant His-tagged lamin A was incubated in kinase reaction
buffer in the presence of c-
32P-ATP either alone (no kinase), with
catalytically deficient GST-UL97 K355Q (K355Q), or with wild-type GST-
UL97 (GST97 WT). GST-UL97 K335Q or wild-type GST-UL97 were also
incubated in kinase buffer without lamin A. Following termination of
kinase reactions, proteins were resolved by SDS-PAGE. Signal from
incorporation of
32P was detected by exposure to a phosphorscreen
(top panel), and total protein was detected by Coomassie brilliant blue
staining (bottom panel). The positions of radiolabeled GST-UL97
(GST97) and lamin A, and Coomassie stained lamin A are indicated.
(The amounts of GST-UL97 were too small to see on the stained gel.) (B)
UL97 autophosphorylation and labeling of lamin A were quantified
following in in vitro kinase reactions in the presence of varying
concentrations of maribavir (MBV). Signal detected from
32P incorpo-
ration for autophosphorylation of GST-UL97 and phosphorylation of
His-tagged lamin A are plotted as a percent of the signal detected in
the absence of drug. The results taken together show that UL97
phosphorylates lamin A in vitro.
doi:10.1371/journal.ppat.1000275.g001
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presence or absence of 1 mM maribavir, which specifically inhibits
UL97 [23,32], or 15 mM roscovitine, which specifically inhibits
CDKs including CDK1 [33,34]. To minimize the effects of kinase
inhibition on earlier stages of the HCMV replication cycle,
infection was allowed to proceed for 69 hours p.i., at which time
nuclear egress has commenced. The infected cells were then
treated with the inhibitors or mock-treated with DMSO-
Figure 2. Phosphorylation sites detected on lamin A/C from HCMV-infected cells and from UL97 treated lamin A in vitro. (A) Mass
spectrum from electrospray ionization (ESI)-MS-MS of SGAQASSTPLpSPTR tryptic peptide (amino acids 12–25 of native lamin A) after phosphorylation
of His-lamin A in vitro with GST-UL97 indicating phosphorylation at Ser
22. Diagnostic fragment ions used to verify detection of the sequence and the
phosphorylation site are indicated in shaded circles and asterisks. A diagram of predicted fragment ions is shown below the spectrum. (B) Mass
spectrum from ESI-MS-MS of LRLpSPSPTSQR tryptic peptide (amino acids 386–397 of native lamin A) after phosphorylation of His-lamin A in vitro with
GST-UL97, indicating phosphorylation at Ser
390. Diagnostic fragment ions are indicated as above. (C) Mass spectrum from ESI-MS-MS of
LRLpSPSPTSQR tryptic peptide (amino acids 386–397 of native lamin A) after phosphorylation of His-lamin A in vitro with recombinant human CDK1/
cyclin B complex, indicating phosphorylation at Ser
390. Diagnostic fragment ions are indicated as above. (D) Representative mass spectrum from ESI-
MS-MS of SGAQASSTPLpSPTR tryptic peptide (amino acids 12–25 of native lamin A) after immunoprecipitation of lamin A/C from HCMV-infected cells
and iTRAQ labeling. Diagnostic fragment ions are presented as above. Note that the iTRAQ label alters the mass of the b-ions. The masses of the ions
from this spectrum are presented in Figure S3. (E) Representative mass spectrum from ESI-MS-MS of LSPpSPTSQR tryptic peptide (amino acids 389–
397 of native lamin A) after immunoprecipitation of lamin A/C from HCMV-infected cells. Diagnostic fragment ions are indicated as above. The results
show that UL97, like CDK1 phosphorylates lamin A on Ser
22 and Ser
390 in vitro, but that phosphorylation occurs on Ser
392 (and Se
r22) in infected cells.
doi:10.1371/journal.ppat.1000275.g002
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of the inhibitors, labeled with [
32P]-orthophosphate for 2 hours.
Following radiolabeling, cells were lysed. Probing western blots of
the lysates with anti-actin antibodies showed that similar amounts
of protein were present in each lysate (Figure 3C), Lamin A/C was
immunoprecipitated from each lysate, the immunoprecipitates
were resolved using SDS-PAGE, and transferred to a membrane.
32P-incorporation into lamin A/C in each sample was measured
by exposing the membrane to a phosphorimager. Then, the
membrane was probed with anti-lamin A/C antibodies to assess
the amounts of lamin A/C in each immunoprecipitate. Similar
amounts of lamins A and C were detected in each sample
(Figure 3A, lower panel); however, there was somewhat more
lamin A and C in the samples from cells treated with maribavir or
maribavir plus roscovitine than in the mock-treated sample.
Despite that, the incorporation of radioactive phosphate into
lamin A and C was visibly less in the sample from infected cells
treated with maribavir compared to mock-treated infected cells,
(Figure 3A, upper panel). Phosphorimager quantification indicated
that the reduction in labeling was approximately 2-fold. In
contrast, the CDK inhibitor roscovitine had a less pronounced
effect on lamin A/C phosphorylation, with radioactive phosphate
incorporation reduced by 20–30% compared to the DMSO
treated control (Figure 3A, upper panel). When both drugs were
present, radioactive phosphate incorporation was reduced by 60–
70% (Figure 3A, upper panel). (Again, there was more lamin A/C,
as detected by immunoblotting, in the sample treated with both
drugs than in the mock-treated control; thus, the actual effect of
the drugs was likely even greater.)
As an additional control, in the same labeling experiment
HCMV UL44 was immunoprecipitated, the immunoprecipitates
were resolved by SDS-PAGE and transfered to a membrane, and
both the amounts of UL44 and the incorporation of
32P into UL44
were measured on the same membrane. In this case, the overall
incorporation of radioactive phosphate into HCMV UL44 was not
reduced by treatment with maribavir, in fact, it was increased
(Figure 3B, upper panel), while the amounts of UL44 were very
similar in all the samples (Figure 3B, lower panel). (Further studies
of UL44 phosphorylation have shown that UL97 phosphorylates
only one or a few sites on UL44, while other kinases phosphorylate
a number of other sites robustly (unpublished results).) Thus,
transient treatment with maribavir exerted a greater inhibitory
effect than transient treatment with a CDK inhibitor on lamin A/
C phosphorylation, while not inhibiting the overall phosphoryla-
tion of a control protein, UL44.
UL97 is required for alterations in the nuclear lamina
during HCMV replication
Morphological deformations of cell nuclei are common in cells
that are defective for lamin A/C [35]. Infection by HCMV has long
been known to cause distortions in nuclear shape [36], and another
study has reported that UL97 mutants do not induce such
deformations [37]. Given our identification of lamin A/C as a
substrate for UL97, we investigated whether these distortions were
associated with alterations in the nuclear lamina. Therefore, we
examined nuclear morphology during infection (MOI=1) by
staining the nuclear lamina with a polyclonal antibody against
lamin A/C, while co-staining for sites of HCMV DNA replication
(replication compartments) usinga monoclonal antibody against the
viral DNA polymerase subunit, UL44 (Figure 4). In immunofluo-
rescence images of mock-infected cells (Figure 4D), the nuclei
stained with the lamin antibody and were oval-shaped with no anti-
UL44 staining. In wt HCMV-infected cells at 96 hours p.i.
(Figure 4A), anti-lamin A/C staining revealed deformed nuclei,
many of which exhibited a kidney shape. This shape was mirrored
by those of the replication compartments stained with anti-UL44.
Wt-infected cells treated with the UL97 inhibitor maribavir
(Figure 4B) and cells infected with a UL97 null mutant virus
(RCD97) (Figure 4C) showed much less dramatic shape changes,
and while nuclei were observed to be somewhat enlarged relative to
mock-infected cells, they often retained an oval shape. In addition,
the anti-lamin staining appeared more uniform around the rim of
the nuclei in mutant-infected cells, maribavir-treated wt-infected
cells, or mock-infected cells than in wt-infected cells (compare
Figure 4A to 4B, 4C and 4D). These kinds of changes in shape and
Table 1. A-type lamin phosphopeptides detected by mass
spectrometry.
Position Sequence
in vitro
(UL97)
Infected
cells
Ser22 SGAQASSTPLpSPTR ++
Ser390 LRLpSPSPTSQR + 2
Ser392 LSPpSPTSQR 2 +
Ser403-Thr409 ApSpSHpSpSQpTQGGGSVTK
a 2 +
Ser414 ASSHSSQTQGGGpSVTK + 2
Ser423/Thr424 KLEpSpTESR
b 2 +
Ser628 pSVGGSGGGSFGDNLVTR + 2
Ser652 SYLLGNSpSPR + 2
A-type lamin phosphopeptides detected after treatment with UL97 in vitro or
detected in HCMV infected cells are indicated with a +. Those that were found
in one setting, but not the other are indicated with a 2.
aSingly phosphorylated peptides with phosphorylation at Ser403, Ser404,
Ser406, Ser407, or Thr409 were each detected.
bPhosphorylation could not be confidently assigned between Ser423 or Thr424.
doi:10.1371/journal.ppat.1000275.t001
Table 2. Comparison of lamin A/C phosphorylation at positions Ser22 and Ser392 during replication of wild-type and UL97 mutant
HCMVs.
Position Phosphopeptide abundance
AD169rv/D97 FLAG97/D97 AD Q355K/AD K355Q
Experiment 1 Experiment 2
Ser22 2.3 3.0 1.8 4.1
Ser392 0.9 0.9 1.1 1.4
The ratios of abundances of the indicated phosphopeptides of lamin A/C from cells infected for 72 hours (MOI=1) with the indicated pairs of viruses were determined
using iTRAQ labeling and LC-MS/MS.
doi:10.1371/journal.ppat.1000275.t002
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24 hours p.i., although less consistently (data not shown).
We then used the same antibodies and confocal microscopy to
investigate these staining patterns and their requirement for active
UL97 in more detail. In wt HCMV-infected cells (MOI=1;
96 hours p.i.), we observed thinning, invaginations (as recently
reported [17]), and, in some cells, discrete gaps in anti-lamin
staining (Figure 5A and 5B) compared to mock-infected cells
(Figure 5E). In contrast, when wt HCMV infection was performed
in the presence of maribavir or when UL97 was ablated genetically
(two independent isolates of a UL97 deletion mutant), the anti-
lamin staining of the nuclear rim resembled that of mock-infected
cells with oval shaped nuclei and little or no thinning and few or
no gaps (Figure 5C and 5D). To quantify the UL97-dependent
changes in nuclear morphology, we surveyed approximately one
hundred nuclei from each infection condition by confocal
microscopy. These results indicated that nuclear deformities
(Figure 6A) and gaps in the nuclear lamina large enough to be
visible by light microscopy (Figure 6B) were each significantly
more frequent under conditions where UL97 kinase activity was
present (p,0.001). Thus, UL97 is required for nuclear deforma-
tion and disruptions of lamina during HCMV infection.
Discussion
We found that UL97 can directly phosphorylate lamin A/C in
vitro on sites phosphorylated in vitro by Cdk1, including Ser
22.W e
also detected UL97-dependent phosphorylation of Ser
22 on lamin
A/C in HCMV-infected cells. Additionally, phosphorylation of
Figure 3. Orthophosphate labeling of lamin A/C during HCMV infection. HCMV-infected cells (MOI=3, 69 hours p.i.) were pulse labeled for
2 hours with [
32P]-orthophosphate in the presence or absence of maribavir or roscovotine or both and then lysed. (A) Lamin A/C immunoprecipitates
were prepared, resolved by SDS-PAGE, and transferred to a PVDF membrane. The membrane was exposed to a phosphorscreen (top panel,
phosphorscreen) to detect
32P signal, and then probed with anti-lamin A/C antibodies to detect total lamin A/C in the immunoprecipitates (bottom
panel, western blot). The signal from the phosphorscreen was quantified and the values for
32P incorporation into lamin A and lamin C are shown
between the upper (phosphorscreen) and lower (western blot) panels. (B) HCMV UL44 immunoprecipitates were prepared from lysates of the same
radiolabeled infected cells, resolved by SDS–PAGE and transferred to a PVDF membrane. The membrane was exposed to a phosphorscreen (top
panel, phosphorscreen) to detect
32P signal, and then probed with anti-UL44 antibodies antibodies to detect total UL44 in the immunoprecipitates
(bottom panel, western blot). The signal from the phosphorscreen was quantified and the values for
32P incorporation into UL44 are shown between
the upper (phosphorscreen) and lower (western blot) panels. (C) The lysates used for immunoprecipitation in A were resolved by SDS-PAGE and
transferred to a PVDF membrane that was probed with anti-actin antibodies. Abbreviations: IP, immunoprecipitate; MBV, maribavir; ROSC,
roscovitine. The results show that transient inhibition of UL97 with maribavir reduces phosphorylation of lamin A/C by about 50%.
doi:10.1371/journal.ppat.1000275.g003
Figure 4. Immunofluorescence of lamin A/C in cells infected
with HCMV. At 96 hours p.i. (MOI=1), cells were fixed and double-
stained with a mouse monoclonal antibody against UL44, a replication
compartment marker (red, left panels) and a goat antibody against
lamin A/C (green, center panels). Signals from both antibodies were
merged (right panels). (A) Wild-type HCMV strain AD169 (AD169)
infected cells show characteristic deformation of the nuclei. The nuclei
of cells infected with AD169 in the presence of 5 mM maribavir
(AD169+MBV) (B) or in cells infected with UL97 deletion mutant virus
RCD97 (D97) (C) retain the oval shape characteristic of mock-infected
cells (mock) (D).
doi:10.1371/journal.ppat.1000275.g004
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kinase activity was transiently inhibited in HCMV-infected cells.
These findings taken together strongly suggest that lamin A/C is a
bona fide, direct substrate of UL97 in infected cells.
Moreover, we found that UL97 is required in infected cells for
discrete changes in the nuclear lamina, including gaps visible by
confocal light microscopy. Given our results on lamin phosphor-
ylation by UL97, we propose a model in which UL97 phosphor-
ylateslaminA/ConSer
22,a site whosephosphorylationisknownto
mediate disassembly of nuclear lamina [5,7]. These phosphoryla-
tion events contribute to localized disruptions in the nuclear lamina.
These disruptions permit access of HCMV nucleocapsids to the
inner nuclear membrane for primary envelopment and budding
intothe spacebetweenthe inner and outer nuclearmembranes,and
thus nuclear egress. This model explains the requirement for UL97
for efficient nuclear egress [19].
We now discuss our results in terms of this model and previous
results regarding lamin phosphorylation and nuclear egress.
UL97 mimics CDK1 for direct phosphorylation of lamin A/C
UL97 directly phosphorylates E. coli expressed lamin A in vitro
with Ser
22 and Ser
390 being the major sites phosphorylated.
Neither of the major sites conforms to a preference of UL97 for
basic residues in the P+5 position [32], although the sites do
contain basic residues at P+6 and P+7. (A minor site (Ser
414)
phosphorylated by UL97 has an Arg at P+5.) More importantly,
the major sites phosphorylated by UL97 were also phosphorylated
in vitro by CDK1/cyclin B1. This result and previous results with
Rb [22] indicate that UL97 can exhibit at least some preference
for sites that CDKs prefer.
UL97-dependent phosphorylation of lamin A/C at Ser
22
in infected cells
We observed UL97-dependent phosphorylation in infected cells
of a site that UL97 phosphorylates directly in vitro, and we found
that transient inhibition of UL97 with maribavir could inhibit
lamin A/C labeling by ,50%. The simplest interpretation of our
data is that UL97 directly phosphorylates lamin A/C in HCMV-
infected cells. An alternative interpretation is that UL97 acts
indirectly, for example, by increasing the activity and/or
expression of host cell kinases that phosphorylate lamin A/C, in
particular CDK1. However, if UL97 were acting indirectly to
increase lamin A/C phosphorylation by increasing CDK activity
or expression, then roscovitine should have been at least as
effective at inhibiting lamin phosphorylation as maribavir. Our
finding that maribavir was more effective than roscovitine is
consistent with UL97 directly phosphorylating lamin A/C rather
than increasing the activity or expression of a CDK. This
interpretation is also consistent with a study that found that
expression of a dominant negative CDK1 did not adversely affect
replication of HCMV [38]; if CDK1 were required for disruption
of nuclear lamina during nuclear egress, such expression might
have been expected to decrease HCMV replication.
Although only one site phosphorylated by UL97 in vitro showed
dependence on UL97 for its phosphorylation in virus infected cells,
it is striking that this position — Ser
22 — is the lamin A/C
phosphoacceptor site of greatest established relevance to dissolu-
tion of lamina [5]. In particular, substitution of Ser
22 with Ala
results in a dominant negative mutant protein that inhibits lamina
disassembly, while substitutions of Ser
392 exert little effect on
lamina disassembly by themselves [5]. Similarly, substitution of
Figure 5. Confocal microscopy of UL97-dependent nuclear
lamina alterations in HCMV-infected cells. At 96 hours p.i.
(MOI=1), cells were fixed and double stained for UL44 (red) and lamin
A/C (green) and imaged by confocal microscopy. Discontinuities in
lamin A/C staining were detected in wt AD169-infected cells (A) and (B)
and are labeled with white arrows. Lamin A/C staining was more
uniform and intense around the nuclear rim and gaps in staining were
rarely observed in cells infected with AD169 in the presence of
maribavir (MBV) (C), when a UL97 deletion mutant virus was used (D97)
(D), or in mock-infected cells (E).
doi:10.1371/journal.ppat.1000275.g005
Figure 6. Quantification of UL97-dependent nuclear lamina perturbations during HCMV infection. (A) Occurrence of nuclear deformity
in fibroblasts infected with HCMV strain AD169 (AD169), AD169 in the presence of maribavir (AD169+MBV), and independent isolates of UL97
deletion mutant RCD97 (RCD97.08) and (RCD97.19). Asterisk denotes Fisher’s exact test p-value of ,0.001 compared to AD169. Numbers above bars
indicate numbers of cells scored. (B) Occurrence of gaps in the nuclear lamina in the same panel of cells scored above for nuclear deformity. Asterisk
denotes Fisher exact test p-value of ,0.001. These results show that UL97 is required for nuclear deformation and disruptions of lamina during HCMV
infection.
doi:10.1371/journal.ppat.1000275.g006
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16, the position equivalent to Ser
22 of lamin A/C,
renders lamin polymers resistant to phosphorylation-mediated
disassembly, while substitutions of serines equivalent to Ser
390 and
Ser
392 have little or no effect [8]. Therefore, our results together
with these previous studies strongly suggest that UL97 phosphor-
ylation of lamin A/C in infected cells at Ser
22 drives lamin A/C
disassembly.
We also detected UL97-independent phophorylation of lamin
A/C in our infected cell preparations. This could be due to the
activities of other kinases in infected cells, due to phosphorylated
lamin A/C that existed prior to infection, and/or due to
phosphorylation occurring in uninfected cells in our samples.
Relationship of UL97 effects on lamins to nuclear egress
In previous studies, it was reported that wt HCMV infection
resulted in drastic reductions in the amounts of A-type lamins
detected on western blots [20,39], and almost complete loss of
lamin staining as detected by immunofluorescence [20], but that
neither was observed during infection by a UL97 mutant [20].
However, we observed copious expression of A-type lamins during
wt HCMV infection, and, similar to the recent report of Camozzi
et al. [17], we observed only discrete changes in lamin staining in
immunofluorescence experiments. The failure of others to detect
lamin A/C in infected cells may be due to using antibodies that fail
to recognize hyperphosphorylated A-type lamins, as previously
asserted [20], or some other form of lamin A/C. Additionally, it
has been reported that expression of UL97 following transient
transfection induces a redistribution of lamin A/C from the
nuclear rim to granular intranuclear structures [20,40]. Whether
this was due to lamin A/C phosphorylation or due to toxicity (e.g.
apoptosis) following UL97 overexpression was unclear. Regardless,
we showed here that UL97 is required for disruptions in the
nuclear lamina in HCMV-infected cells.
The simplest explanation for this requirement is that limited
phosphorylation of lamins by UL97 causes local disassembly of the
lamina. Although we detected gaps visible by confocal light
microscopy in only a minority of cells, we emphasize that such
gaps are much larger than an HCMV nucleocapsid. We think it is
highly likely that nearly all infected cells contain smaller gaps in the
lamina that could readily permit access of HCMV nucleocapsids to
the inner nuclear membrane during nuclear egress. It may be
advantageous for HCMV to induce only localized disruptions of the
nuclear lamina. Lamins are important for cellular chromatin
organization,DNAsynthesis and transcription [3,35],and thus may
play important roles in herpesvirus infection in addition to their
service as barriers for nuclear egress. Indeed, during HSV infection,
lamin A/C is required for proper targeting of the viral genome and
for reduction of heterochromatin formation on viral promoters at
early times of infection [41]. Nevertheless, there is more extensive
disruption of the nuclear lamina during HSV infection than what
we observed during HCMV infection [42,43].
The requirement for UL97 for the characteristic kidney-shape
of nuclei in HCMV-infected cells is consistent with the results of
Azzeh et al. [37]. The concave invaginations found in these nuclei
are typically adjacent to juxtanuclear structures that appear to be
cytoplasmic sites of virion assembly [44], and whose morphology
depends on UL97 [37]. It is possible that the earliest UL97-
mediated lamin disruptions (we detected gaps in some cells at
24 hours p.i. (data not shown) direct the passage of primary
enveloped virions into a particular portion of the perinuclear
cytoplasm, and this contributes to the organization of the
juxtanuclear structure. Alternatively or additionally, UL97 may
prevent aggregation of tegument proteins in the nucleus [45] or be
more directly required for formation of the juxtanuclear structure
[37]. As noted by Azzeh et al. [37], the juxtanuclear structure
seems to impact the nucleus. Thus, it may exert the force that
causes deformation of the lamin-depleted nuclear envelope.
A considerable body of evidence establishes that HCMV UL50
andUL53andtheirhomologsinotherherpesvirusesplayimportant
roles in nuclear egress (reviewed in [2]). It has been proposed that
these proteins and their homologs alter the nuclear lamina by
recruiting PKCs to phosphorylate lamins [15,16,17,46,47]. How-
ever, PKC phosphorylation of nuclear lamins normally occurs
during interphase and is not sufficient to cause dissolution of lamina
[6,25]. Moreover, we did not observe phosphorylation of lamin A/
C in HCMV-infected cells at sites known or likely to be
phosphorylated by PKC, including Ser
5, Thr
199, Ser
395,T h r
416,
Thr
480, and Ser
652 [7,25]. It may be that UL50 and UL53 act by
recruiting PKC to disassemble nuclear lamina, but that the relevant
substrate of PKC is lamin B [48] or other nuclear envelope
components such as emerin [49,50]. Alternatively, the roles of
UL50 and UL53 during nuclear egress may be independent of
protein kinase recuitment. Recently, Camozzi et al. [17] reported
that transient overexpression of HCMV UL50 and UL53 was
sufficient to induce changes in the distribution of lamin A/C akin to
what is observed during HCMV infection. Regardless, during
HCMV infection, in the absence of UL97, nuclei remain oval and
lamin staining remains intact despite the presence of UL50 and
UL53. Thus, much as CDK1 is the crucial kinase for dissolution of
lamina during mitosis, UL97, which mimics CDK1 for phosphor-
ylation of lamin A/C, is the crucial kinase for nuclear egress.
Why mimic CDKs?
Why has HCMV evolved to encode a kinase that mimics CDK1
for phosphorylation of lamin A/C? One possible explanation
stems from HCMV arresting the cell cycle at the G1/S boundary
[9,10,11]. CDK1 is most active in phosphorylating nuclear lamina
during M-phase [6]. There are elevated levels of CDK1 and cyclin
B1 in HCMV-infected cells [12,13,14], which may account for the
phosphorylation of Ser
22 and Ser
392 on lamin A/C that we
detected even in the absence of UL97. It is also possible that this
phosphorylation contributes to disruption of the nuclear lamina.
However, expression of a dominant negative CDK1 did not
decrease HCMV replication [38], CDK1 and cyclin B do not
appear to accumulate in the nuclei of infected cells to the extent
seen in mitotic cells [14], and their elevated levels evidently are not
sufficient to disrupt the nuclear lamina by themselves. Interest-
ingly, CDK1 does appear to be required in HCMV-infected cells
for the formation of so-called pseudomitoses, in which aberrant
spindle poles and chromosome condensation occur [38], and
CDKs that are sensitive to roscovitine are involved in several
phases of HCMV replication [51].
UL97 mimicry of a CDK for phosphorylation of lamin A/C
explains at least part of this viral enzyme’s role in HCMV infection.
It is notable that UL97 is also required for phosphorylation of a
second CDK substrate, Rb, in infected cells [22,52]. As yet, the
importance of phosphorylation of Rb for HCMV replication has
not been established. It will be interesting to elucidate further how
HCMV uses its CDK-mimic to promote its propagation.
Materials and Methods
Reagents
All reagents were from Sigma unless otherwise specified.
Cells and viruses
HFF cells, isolate Hs27, (American Type Culture Collection)
were cultured in Dulbecco’s modified Eagle’s medium (DMEM)
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described previously [31]. HCMV wt strain AD169 was obtained
from the American Type Culture Collection. Two independent
isolates of RCD97, RCD97.08 and RCD97.19, derived from
AD169 and containing the Escherichia coli lacZ and gpt genes
replacing most of UL97 [24], were generously provided by Mark
Prichard (University of Alabama, Birmingham). In some experi-
ments, AD169rv [53], a bacterial artificial chromosome (BAC)
clone of HCMV strain AD169, as well as more recently
constructed viruses derived from AD169rv, were used: D97, a
BAC derived UL97 deletion mutant, FLAG97 a rescuant of D97,
AD K355Q, and AD Q355K [22,31]. Viral stocks were
propagated and titrated as previously described [31].
Two-dimensional (2D) gel analysis of phosphoproteins
HFF cells were infected at a multiplicity of infection (MOI) of 1
PFU/cell (inoculum titers were confirmed by back titration) in
complete medium (DMEM containing 5% FBS) for 2 h. Inocula
were removed, and the cells were washed two times with complete
medium. Complete medium, either with or without 1 mM
maribavir, was then added and incubation was continued at
37uC. At 3 days post infection (p.i.), cells were rinsed twice with
inorganic phosphate-free DMEM (Invitrogen) containing 1% FBS
and were then incubated in 2 ml of that medium containing
1 mCi of [
32P]-orthophosphate for 2 h. The medium was
removed, and the cells were rinsed twice in ice-cold Tris-buffered
saline (TBS: 20 mM Tris HCl pH 7.5, 150 mM NaCl) and then
scraped into ice-cold TBS. 2D gel electrophoresis was performed
by isoelectric focusing (IEF) using Immobiline Dry Strips with a
pH gradient from 3 to 10 (GE Healthcare Inc.) in the first
dimension and 4 to 20% (Invitrogen) SDS-PAGE in the second
dimension as described [54]. Proteins were transferred for
30 minutes at 20 V to a BioTrace Polyvinylidene Fluoride (PVDF)
membrane (Pall Corporation, Pensacola, Florida), such that
approximately half of the protein was transferred and half
remained in the gel.
32P signal from proteins transferred to PVDF
was visualized by exposure to a phosphorscreen or Bio-Max Film
(Kodak), and remaining protein in the gel was stained with Gel
Code Blue colloidal coomassie blue staining reagent (Pierce) and
was kept for subsequent MS analysis.
Protein expression and purification
A pET19b vector (EMD Chemicals, Inc.) which was modified to
incorporate a human rhinovirus 3C protease cleavage site following
the pET19b polyhistidine tag, a generous gift from Tapan Biswas
(Harvard Medical School), was used to express lamin A in E. coli.
The lamin A sequence was amplified by PCR with an upstream
primer (59CCCCATATGATGGAGACCCCGTCCCAG39) con-
taining a NdeI site, and a downstream primer (59TTGCTCGAGT-
CATGATGCTGCAGTTCTG39) containing a XhoI site (restric-
tion sites are in italics), from plasmid pJB311 [55], kindly provided
by Joel Baines (Cornell University). The resulting plasmid was used
to transform E. coli BL21 (DE3) CodonPlus bacteria (Stratagene),
and expression was induced at an optical density of 595 nm of 0.5,
protein expression was induced with 0.5 mM isopropyl-b-D-
thiogalactopyranoside (IPTG) for 20 h at 16uC. Inclusion bodies
were isolated and dissolved in 8 M urea, 50 mM Tris-HCl pH 8.0,
0.5 M NaCl, 1 mM dithiothreitol (DTT), 20 mM imidazole and
Complete
TM protease inhibitor (Roche, 1 tablet/50 ml). The
protein was then purified using a nickel column (Amersham
Pharmacia) using the same urea buffer with a 20 to 1 M imidazole
gradient. Proteins were concentrated and stored frozen and, when
required were renatured by dialysis against 0.5 M NaCl, 50 mM
Tris-HCl pH 8, 1 mM DTT and protease inhibitors.
GST-UL97 (WT) and GST-UL97 K355Q were expressed from
baculovirus vectors as previously described [56], except that in
some experiments, newly generated baculoviruses were used to
express GST-UL97 and GST-UL97 K355Q fusion proteins.
These baculoviruses were based on the Bac-to-Bac system
(Invitrogen, Inc., Carlsbad, California) and derived from custom-
ized pFASTBAC transfer vectors incorporating an N-terminal
glutathione S-transferase tag. Protein concentrations were deter-
mined by amino acid analysis at the Molecular Biology Core
Facility, Dana-Farber Cancer Institute.
Protein kinase assays
For radioactive in vitro kinase assays, 32 ng of GST-UL97 or
GST-UL97 K355Q was used with 0.6 mg of His-lamin A per
20 mL reaction in 50 mM Tris (pH 8.5 at 37uC), 125 mM NaCl,
5% glycerol, 10 mM MgCl2, 2 mM DTT, 5 mM betaglyceropho-
sphate, 100 mM unlabeled ATP and 0.5 mLo f[ c-
32P]-ATP (3,000
to 6,000 Ci/mmol) (Perkin Elmer Inc., Waltham, MA) and
incubated at 37uC for 90 min. For non-radiactive kinase reactions
submitted for MS analysis, reactions were scaled up to 120 mL and
2 mg of UL97 or 160 ng of CDK1/cyclin B complex (Cell
Signaling Technology, Inc., Danvers, MA) was used, and the final
ATP concentration was adjusted to 200 mM. For comparison of
maribavir inhibition of UL97 autophosphorylation versus lamin A
phosphorylation, the same reaction conditions were used except
50 ng GST-UL97, 0.5 mg of His-lamin A, 50 mM Tris (pH 9.0 at
25uC), 300 mM NaCl, 1 mM DTT, 10 mM MgCl2, 0.5 ml of
[c-
32P]-ATP (3,000 to 6,000 Ci/mmol) (Dupont NEN) and
specified concentrations of maribavir were combined in a final
volume of 10 ml and incubated at 37uC for 2 h. Reactions were
terminated by the addition of concentrated SDS-PAGE loading
buffer. Samples were heated at 95uC for 5 min and proteins were
resolved by SDS-PAGE. Gels were dried onto blotting paper
under vacuum, and incorporated
32P was quantified with a
phosphorimager (Molecular Imager FX System; Bio-Rad Labo-
ratories Inc., Hercules, California).
Immunoprecipitation and western blotting
For immunoprecipitations of lamin A/C for MS analysis, HFF
were infected at an MOI of 1.0 (confirmed by back-titration). At 72 h
post infection, cells were rinsed. In non-radioactive experiments, cells
were rinsed twice in ice-cold Dubecco’s phosphate buffered saline
prior to lysis. For radioactive experiments, cells were rinsed three
times in 0.5 mL of ice-cold Tris-buffered saline (25 mM Tris pH 8.0,
4 mMKCl,137 mMNaCl)priortolysis.Cellswerelysedfor30 min
at 4uC in 0.5 mL of ice-cold modified radio-immunoprecipitation
assay(RIPA)bufferperwell.TheRIPAbufferusedwassimilartoone
previously described [57] except that 300 mM NaCl was used,
Triton-X 100 (1%) was used in place of NP-40, and the following
components were added: 10 mM EDTA, 10% glycerol, 10 mM
betaglycerophosphate, 5 mM NaF, 10 mg/mL each of leupeptin and
aprotinin, 1 mg/mL pepstatin A, 10 mM E-64, 2 mM imidazole,
1.2 mM sodium molybdate, 0.5 mM sodium orthovanadate, 4 mM
sodium tartrate, 1 mM DTT, and Calbiochem Phosphatase
Inhibitor Set I (EMD Chemicals Inc., Gibbstown, New Jersey) was
added at 1:100. Lysates were collected and clarified at 10,000 g at
4uC and supernatants were transferred to new tubes, flash frozen on
liquid N2,a n ds t o r e da t280uCu n t i lu s e .
Two hundred microliters of each thawed lysate was pre-cleared,
with rotation, for 30 min at 4uC with 10 mg each of purified mouse
IgG1 and IgG2a (Bethyl Labs Inc., Montgomery, Texas) and
20 mL of settled Immunopure Protein A/G (Pierce) in a final
volume of 0.5 mL (adjusted by adding RIPA buffer). Then,
220 mL of each sample was added to 15 mL of Protein A/G, which
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anti-lamin A/C monoclonal antibodies (Millipore Inc., Billerica,
Massachusetts). IP reactions were adjusted to a final volume of
0.5 mL with RIPA buffer and allowed to rotate for 1 h at 4uC. IP
reactions were then subjected to four 5 min washes in 0.5 mL
RIPA buffer and then incubated at 85uC for 5 min in 80 mLo f2 6
SDS-PAGE sample buffer [57] supplemented with 5% betamer-
captoethanol. Immunoprecipitation of lamin A/C from non-
radiolabeled cells was performed essentially as above except
without pre-clearing.
For immunoprecipitation of HCMV UL44, each sample of cells
was lysed in 1 ml EBC2 lysis buffer (50 mM Tris [pH 8.0],
30 mM NaCl, 0.5% NP-40, 2 mM EDTA and 2 mM DTT)
supplemented with 10 mg/mL each of leupeptin and aprotinin,
1 mg/mL pepstatin A, 25 mM betaglycerophosphate, 0.5 mM
sodium orthovanadate, and 1:100 of Phosphatase Inhibitor
Cocktail 1 and 2 (Sigma). Lysates were pre-cleared then reacted
with anti-UL44 antibody 28-21 (kindly provided by William Britt,
U. of Alabama) pre-conjugated to Protein A beads. The
immunoprecipitations were washed four times in 1 mL cold
EBC2 lysis buffer, and resuspended in 40 mL2 6 SDS-PAGE
sample buffer.
SDS-PAGE and western blotting procedures were carried out as
previously described [58] using goat anti-lamin A/C polyclonal
antibody N-18 (Santa Cruz Biotechnology), anti-CMV ICP36
(UL44) monoclonal antibody-ViruSelect (Virusys), or anti-beta-
actin mouse monoclonal antibody (Abcam) to probe immunoblots.
MS analysis
In early experiments, following SDS-PAGE, lamin A from in
vitro phosphorylation reactions or lamin A/C from infected cells in
gel slices was reduced and alkylated by DTT and iodoacetamide,
respectively. The gel slices werethen dehydratedin acetonitrile, and
the protein digested with trypsin (500 ng/slice) in NH4HCO3 buffer
(50 mM, 50 mL/slice) overnight at 37uC. Trypsin-digested peptide
samples were then enriched for phophopeptides using a phopho-
peptide isolation kit (Pierce). The samples were mixed with binding
buffer (10% acetic acid), followed by addition of sample mix (50 mL)
to SwellGel Disc (Pierce) resin. The sample-resin mixture, whose
pH was maintained below 3.5, was incubated for 8 minutes at room
temperature with regular gentle swirling. Resin was washed twice in
50 mL of 0.1% acetic acid, and twice in 50 mL of 0.1% acetic acid,
10% acetonitrile. Phosphopeptides were eluted in elution buffer
(50 mL, 100 mM ammonium bicarbonate, pH 9.0) after 5 minutes
incubation. Eluted phophopeptides were analyzed by LC-MS/MS
at the Taplin Biological Mass Spectrometry Facility at Harvard
Medical School.
Subsequent experiments were performed using different proto-
cols depending on whether phosphorylation was assessed following
in vitro phosphorylation or following phosphorylation in infected
cells. For analyses of in vitro phosphorylated samples, the kinase
reactions were treated with 1 mg trypsin (Promega) in 100 mM
ammonium bicarbonate pH 8.0 (overnight, 37uC), and lyophilized.
Free peptide carboxylate groups were converted to their corre-
sponding methyl esters and the derived peptides were subjected to
phosphopeptide enrichment as described previously [59]. Captured
phosphopeptides were eluted with 50 mM PO4 buffer pH 8.0
directly onto a 100 mm (i.d.)68 cm fused silica capillary desalting
precolumn (PC) packed with 10/25 irregular-shaped C18 beads.
ThePCwas then connectedtoa 50 mm68c m( 5mmsphericalC18
beads) analytical column. LC-MS/MS was performed on a
QSTAR XL (MDS SCIEX). The HPLC solvent gradient was 0–
7%Bin5 min,7–63%Bin30 min;solventAwas0.2 Maceticacid
and solvent B was 70% acetonitrile/0.2 M acetic acid.
In later experiments aimed at comparing the phosphorylation
sites of UL97 and CDK1 on lamin A/C, in vitro phosphorylated
lamin A/C was digested as described above and each digest was
analyzed separately on an LTQ-Orbitrap mass spectrometer
(ThemoFinnigan) using a method consisting of two data-
dependent MS/MS scans, followed by targeted MS/MS scans
on precursors corresponding to lamin A/C peptides containing
Ser
22, Ser
392, their phosphorylated counterparts, and a synthetic
pS392 peptide (LSPpSPTSQR) containing 6
13C and 4
15N atoms.
This synthetic peptide was loaded onto the PC as an internal
control.
For analysis of lamin A/C phosphorylated in cells, lamin A/C
immunoprecipitates was processed for subsequent iTRAQ (Ap-
plied Biosystems) isotope labeling according to the manufacturer’s
protocol. Briefly, each sample was separately reduced using 5 mM
Tris-(2-carboxyethyl)phosphine (TCEP) (1 hr, 60uC), alkylated
using 10 mM methyl methane-thiosulfonate (MMTS) (10 min,
room temperature) and digested on the beads with trypsin
(Promega) in 0.5 M triethylammonium bicarbonate pH 8.5
(overnight, 37uC). The resulting peptides were then labeled with
iTRAQ-114 (mock), iTRAQ-115 (AD K355Q), iTRAQ-116
(D97) and iTRAQ-117 (AD169rv) reagents in 70% ethanol,
respectively, for 1 hr at room temperature. Following iTRAQ
labeling, all four samples were combined and dried by centrifugal
concentration (Thermo Savant, Holbrook, New York). To enrich
for phosphorylated lamin A/C peptides, 100 ml of 100 mg/ml
MassPREP Enhancer in 80% acetonitrile/0.1% trifluoroacetic
acid (TFA) were added. After sonication (20 min), the mixed
sample was loaded on a well of a TiO2 96-well plate (Waters,
Milford, Massachusetts). Peptides were eluted with 100 mlo f
300 mM ammonium hydroxide. Following elution, 3 ml of TFA
were added to the sample to bring the pH to 2.0 and the sample
volume was reduced to ,20 ml by centrifugal concentration. LC-
MS/MS was performed on a QSTAR XL using a Top 3 method.
A similar protocol was followed for analysis of AD169rv- (iTRAQ
114), D97-(iTRAQ 115), FLAG97 (WT rescue of D97)- (iTRAQ
116), mock-(iTRAQ 117), AD K355Q-(iTRAQ 114) and AD
Q355K-(iTRAQ 115) HCMV-infected cells, except that a
targeted MS/MS method (on phosphorylated Ser
22 and Ser
392)
was used for the phosphopeptides and a Top 6 was used for the
TiO2 loading flowthrough. Non-phosphorylated lamin peptides
detected in the loading flowthrough were used to normalize
abundances of phosphorylated peptides. As described above, an
isotopically labeled synthetic phosphopeptide containing a phos-
phate on Ser
392 was loaded onto the PC as an internal standard.
MS/MS spectra were searched against an in-house lamin A/C
database and the human RefSeq database using the Mascot
algorithm. Putative lamin A/C phosphopeptide sequences were
manually confirmed.
Transient inhibition of protein kinase activities in cells
2610
5 HFF per well of a 24 well cluster plate were infected at a
MOI of 3 (confirmed by back titration) and then incubated at
37uC in DMEM supplemented with 5% FBS. Sixty-nine hours
post infection, medium was removed and cells were washed with
phosphate-free DMEM (Invitrogen Inc.) and incubated for 1 hour
in 0.5 mL phosphate free medium containing 2% FBS, supple-
mented with 15 mM roscovitine or 1 mM maribavir, both drugs, or
no drug. The concentration of DMSO was adjusted to a final
concentration of 0.2% (vol/vol) to control for any effects of the
carrier. Five hundred microcuries of
32P-labeled orthophosphoric
acid (8500–9120 Ci/mmol) was then added in 0.5 mL of
phosphate free medium containing 2% FBS and the same drug
condition used during the pre-incubation step and left on the cells
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as described above and analyzed by SDS-PAGE and autoradiog-
raphy and western blotting as described above.
Immunofluorescence
HFF were seeded for at 1610
5 cells/well on glass coverslips in
24-well dishes and allowed to attach overnight prior to infection at
an MOI of 1. At 96 h post infection, cells were fixed in 4%
formaldehyde in PBS for 20 min (unless otherwise indicated, all
steps were performed at room temperature). Cells were permea-
bilized with acetone at 220uC for 2 min. Following several washes
in PBS, cells were blocked overnight in IF buffer (PBS containing
4% FBS [Sigma]). Primary antibodies were diluted in IF buffer
and incubated with fixed cells for 1 h. Lamin A/C goat polyclonal
antibody N-18 (Santa Cruz Biotechnology, Inc.) was used at 1:10
dilution and UL44 mouse monoclonal antibody 10-C50 (Fitzger-
ald Industries International Inc.) was used at 1:100. Secondary
antibodies (Alexa Fluor 568-rabbit anti-mouse IgG and Alexa 488-
chicken anti-goat IgG, Invitrogen) were applied at 1:1,000. Cells
were then washed in IF buffer three times for 5 min per wash, and
mounted on slides in Prolong Antifade reagent (Molecular Probes,
Inc.). Fluorescence microscopy was performed in the Nikon
Imaging Center at Harvard Medical School, using a Nikon
TE2000U inverted microscope in conjunction with a PerkinElmer
Ultraview spinning disk confocal system equipped with a
Hamamatsu Orca ER cooled-CCD camera. Images were
acquired using a 606 differential interference contrast oil
immersion objective lens and analyzed using Metamorph software
from Universal Imaging, Inc. (Downingtown, Pennsylvania).
Fisher’s exact test was performed using Prism 4 (GraphPad
Software, Inc.) for Macintosh.
Supporting Information
Table S1 Candidate UL97 substrates. Protein description,
database hit, and peptides detected for those polypeptides for
which at least two distinct peptides were detected in one or more
experiments are shown.
Found at: doi:10.1371/journal.ppat.1000275.s001 (0.05 MB
DOC)
Figure S1 2D electrophoresis. Samples from HFF cells infected
with HCMV wt strain AD169 in the absence of drug (left-most
panels), UL97 null mutant RCD97 in the absence of drug (middle
panels), and AD169 in the presence of 1 mM maribavir (MBV;
rightmost panels) that had been radiolabeled with 32P orthophos-
phate were resolved by isoelectric focusing in one dimension
(arrows above each panel point to lower pIs) and by SDS-PAGE in
the second dimension (arrows to the left of the panels point to
lower molecular weight (Mr). Top panels (A) show autoradiograms
of the 2D gels; the red rectangles indicate the areas from which
spots from wt-infected cells differed from those in the other two
samples were taken. Bottom panels (B) show an expanded region
of the gels in the top panels. Spots numbered 1–6 from wt-infected
cells were excised from the gels and submitted for MS analysis.
Lamin A/C peptides were found in spot 6.
Found at: doi:10.1371/journal.ppat.1000275.s002 (8.95 MB TIF)
Figure S2 Purification of recombinant lamin A. His-lamin A
was expressed in E. coli, the bacterial cells were lysed and His-
lamin A/C was purified as a fusion protein using nickel affinity
chromatography as described in Materials and Methods. Aliquots
of the initial crude protein extract derived from inclusion bodies
(crude), the flow through, the first wash (wash 1), the second wash
(wash 2), and the eluate (lanes indicated above the image of the gel)
were resolved by SDS-PAGE alongside molecular weight markers
(M) and detected by Silver Blue staining. The position of His-
lamin A is indicated to the right of the gel. By this procedure,
sufficient amounts of reasonably pure lamin A were obtained.
Found at: doi:10.1371/journal.ppat.1000275.s003 (0.03 MB PDF)
Figure S3 Diagram of predicted fragment ions from spectrum in
Fig. 2D. The sequence of the peptide is shown on the top line, with
the position of the iTRAQ label indicated. Below are the masses of
the various series of ions.
Found at: doi:10.1371/journal.ppat.1000275.s004 (2.11 MB TIF)
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